Jazz Pharmaceuticals (JAZZ) Current Taxes (2012 - 2026)

Jazz Pharmaceuticals' Current Taxes history runs 15 years deep, the most recent figure standing at $93.7 million for Q1 2026.

• In Q1 2026, Current Taxes rose 195.01% year-over-year to $93.7 million; the TTM figure through Mar 2026 stood at $93.7 million (up 195.01% YoY), while the FY2025 annual figure was $56.3 million, up 200.15% from the prior year.
• Current Taxes for Q1 2026 stood at $93.7 million, up from $56.3 million in the prior quarter.
• The five-year high for Current Taxes was $93.7 million in Q1 2026, with the low at $5.8 million in Q2 2022.
• The 5-year median for Current Taxes is $49.3 million (2024), against an average of $47.6 million.
• The sharpest annual moves came in 2022 and 2023: Current Taxes slumped 69.51% in 2022, then surged 1065.1% in 2023.
• Jazz Pharmaceuticals' Current Taxes stood at $7.7 million in 2022, then soared by 354.5% to $35.1 million in 2023, then sank by 46.52% to $18.8 million in 2024, then surged by 200.15% to $56.3 million in 2025, then surged by 66.43% to $93.7 million in 2026.
• Business Quant data shows JAZZ's Current Taxes at $93.7 million in Q1 2026, $56.3 million in Q4 2025, and $91.1 million in Q3 2025.